{
    "title": "Britain widens access to Pfizer's COVID antiviral drug through trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10709419/Britain-widens-access-Pfizers-COVID-antiviral-drug-trial.html",
    "date": "2022-04-11",
    "keywords": [
        "trial",
        "health",
        "study",
        "paxlovid",
        "risk",
        "covid",
        "alistair",
        "access",
        "covid19",
        "treatment",
        "population",
        "ministry",
        "pill",
        "britain",
        "minister",
        "molnupiravir",
        "drug",
        "tuesday",
        "combination",
        "ritonavir",
        "england",
        "number",
        "adult",
        "death",
        "hospitalisation",
        "month",
        "boris",
        "johnson",
        "part",
        "plan",
        "virus",
        "protection",
        "way",
        "cuttingedge",
        "countrys",
        "sajid",
        "javid",
        "statement",
        "age",
        "merck",
        "amp",
        "co",
        "ridgeback",
        "panoramic",
        "reporting",
        "smout",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}